Recognition and management of adverse cutaneous reactions in patients on enfortumab vedotin and pembrolizumab in the inpatient setting - Emma L. Myers, BA; Jessica Liu, BA; Sabrina M. Shearer, MD; Sarah A. Myers, MD; Michelle Schneider, MB, BCh, BAO; Christopher Hoimes, DO; Melodi Javid Whitley, MD, PhD (JAAD Case Reports)